{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-225041","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2025-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.248632+00:00","generated_at":"2026-05-17T05:15:29.752431+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sight Sciences extends interest-only period to Feb 2027, ups Tranche 3 to $25M","bullets":["Interest-only period extended six months to February 1, 2027.","Tranche 3 availability increased from $15M to $25M, drawable in $5M increments subject to Hercules' sole approval.","Company paid $50,000 amendment fee plus expenses; total $65M facility unchanged.","Performance Milestone II and Interest Only Extension Conditions removed from loan agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-225041","json":"https://secwatch.observer/filing/0001193125-25-225041.json","markdown":"https://secwatch.observer/filing/0001193125-25-225041.md","text":"https://secwatch.observer/filing/0001193125-25-225041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000119312525225041/0001193125-25-225041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000119312525225041/sght-20250930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:15:29.752431+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}